1. Guideline on the investigation of bioequivalence (CPMP/EWP/QWP/1401/98 rev.1/corr **). London;European Medicines Agency,2010
2. Committee for Medicinal Products for Human Use (CHMP). Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues (EMEA/CHMP/BMWP/42832/2005 Rev1). London;European Medicines Agency,2014
3. Consideration of individual bioequivalence;Anderson;J Pharmacokinet Biopharm,1990
4. Individual bioequivalence testing under 2x3 designs;Chow;Stat Med,2002